39 related articles for article (PubMed ID: 373922)
1. Folinic Acid Over: Rescue of Intermediate Dose Methotrexate.
Cohen IJ
Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):269-270. PubMed ID: 38135635
[No Abstract] [Full Text] [Related]
2. Exploratory analysis of the TREAT EARLIER trial: is the efficacy of temporary methotrexate treatment dose-dependent?
Krijbolder DI; Boom HD; van der Helm-van Mil AHM
Lancet Rheumatol; 2023 Aug; 5(8):e437-e439. PubMed ID: 38251573
[No Abstract] [Full Text] [Related]
3. Combination chemotherapy (high-dose methotrexate with citrovorum factor rescue, mechlorethamine, and procarbazine) in non-small cell lung cancer.
Bhasin RR; Nogeirie CP
Cancer Chemother Pharmacol; 1983; 11(2):106-7. PubMed ID: 6605217
[TBL] [Abstract][Full Text] [Related]
4. High-dose methotrexate with folinic acid rescue.
Bender JF; Grove WR; Fortner CL
Am J Hosp Pharm; 1977 Sep; 34(9):961-5. PubMed ID: 333910
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic agents: high-dose methotrexate and citrovorum factor rescue.
Sadée W
Ther Drug Monit; 1980; 2(2):177-85. PubMed ID: 6762711
[TBL] [Abstract][Full Text] [Related]
6. High-dose methotrexate with citrovorum factor rescue in non-small-cell lung cancer.
Greco FA; Fer MF; Richardson RL; Hande KR; Van Boxtel CJ; Oldham RK
Cancer Chemother Pharmacol; 1978; 1(4):255-7. PubMed ID: 373922
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of high-dose methotrexate in the treatment of patients with non-small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study.
Ettinger DS; Stanley KE; Nystrom JS
Cancer Treat Rep; 1980; 64(10-11):1017-21. PubMed ID: 6970075
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
Barlow JJ; Piver MS
Cancer Treat Rep; 1976 May; 60(5):527-33. PubMed ID: 1086714
[TBL] [Abstract][Full Text] [Related]
9. Second-line efficacy of intermediate high-dose methotrexate with citrovorum factor rescue + cyclophosphamide in ovarian cancer.
Barlow JJ; Piver MS
Gynecol Oncol; 1979 Apr; 7(2):233-8. PubMed ID: 312234
[No Abstract] [Full Text] [Related]
10. Phase I trial of high-dose methotrexate with modified citrovorum factor rescue.
Jacobs SA; Santicky MJ
Cancer Treat Rep; 1978 Mar; 62(3):397-9. PubMed ID: 348306
[No Abstract] [Full Text] [Related]
11. Oral high-dose methotrexate with citrovorum factor rescue in metastastic squamous cell carcinoma of the lung.
Tornyos K; Faust H
Cancer; 1978 Feb; 41(2):400-2. PubMed ID: 305283
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the antileukemic potency of the antimetabolite aminopterin, administered alone and in combination with citrovorum factor or folic acid.
GOLDIN A; MANTEL N; GREENHOUSE SW; VENDITTI JM; HUMPHREYS SR
Cancer Res; 1953 Dec; 13(12):843-50. PubMed ID: 13116122
[No Abstract] [Full Text] [Related]
13. The mechanism of action of methotrexate. II. Augmentation by vincristine of inhibition of deoxyribonucleic aic synthesis by methotrexate in Ehrlich ascites tumor cells.
Goldman ID; Fyfe MJ
Mol Pharmacol; 1974 Mar; 10(2):275-82. PubMed ID: 4859543
[No Abstract] [Full Text] [Related]
14. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.
Jaffe N; Frei E; Traggis D; Bishop Y
N Engl J Med; 1974 Nov; 291(19):994-7. PubMed ID: 4606174
[No Abstract] [Full Text] [Related]
15. Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer.
Djerassi I; Rominger CJ; Kim JS; Turchi J; Suvansri U; Hughes D
Cancer; 1972 Jul; 30(1):22-30. PubMed ID: 4537740
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
